These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29436251)

  • 41. Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial.
    Raviteja KV; Kumar R; Dayal D; Sachdeva N
    Sci Rep; 2019 Apr; 9(1):6120. PubMed ID: 30992480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5).
    Schneider B; Martin S; Heinemann L; Lodwig V; Kolb H
    Arzneimittelforschung; 2007; 57(12):762-9. PubMed ID: 18380408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
    Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies.
    Franciosi M; Pellegrini F; De Berardis G; Belfiglio M; Cavaliere D; Di Nardo B; Greenfield S; Kaplan SH; Sacco M; Tognoni G; Valentini M; Nicolucci A;
    Diabetes Care; 2001 Nov; 24(11):1870-7. PubMed ID: 11679449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus.
    Oyagüez I; Merino-Torres JF; Brito M; Bellido V; Cardona-Hernandez R; Gomez-Peralta F; Morales-Perez F
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32699114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
    Willis WD; Diago-Cabezudo JI; Madec-Hily A; Aslam A
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):123-30. PubMed ID: 23402452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France.
    Roze S; Smith-Palmer J; Valentine W; Payet V; de Portu S; Papo N; Cucherat M; Hanaire H
    Diabetes Technol Ther; 2016 Feb; 18(2):75-84. PubMed ID: 26646072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
    Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
    Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.
    Roze S; Saunders R; Brandt AS; de Portu S; Papo NL; Jendle J
    Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trial.
    Schipfer M; Albrecht C; Ehrmann D; Haak T; Kulzer B; Hermanns N
    Trials; 2018 Feb; 19(1):91. PubMed ID: 29402319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
    Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.
    Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabetes Care; 2020 Sep; 43(9):2153-2160. PubMed ID: 32669277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Promoting health and reducing costs: a role for reform of self-monitoring of blood glucose provision within the National Health Service.
    Leigh S; Idris I; Collins B; Granby P; Noble M; Parker M
    Diabet Med; 2016 May; 33(5):681-90. PubMed ID: 26443548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improvement of metabolic control after 3-month use of real-time continuous glucose monitoring in patients with type 1 diabetes: a multicenter study in Greece.
    Eleftheriadou I; Didangelos T; Pappas AC; Anastasiou E; Vasilopoulos C; Zoupas C; Manes C; Tsatsoulis A; Benroubi M; Pangalos E; Thomakos P; Gerasimidi-Vazeou A; Tentolouris N
    Hormones (Athens); 2019 Dec; 18(4):443-450. PubMed ID: 31721132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events.
    Farmer A; Balman E; Gadsby R; Moffatt J; Cradock S; McEwen L; Jameson K
    Curr Med Res Opin; 2008 Nov; 24(11):3097-104. PubMed ID: 18828957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Moreno-Fernandez J; Pazos-Couselo M; González-Rodriguez M; Rozas P; Delgado M; Aguirre M; Garcia-Lopez JM
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):556-563. PubMed ID: 29907546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control.
    Franciosi M; Pellegrini F; De Berardis G; Belfiglio M; Di Nardo B; Greenfield S; Kaplan SH; Rossi MC; Sacco M; Tognoni G; Valentini M; Nicolucci A;
    Diabet Med; 2005 Jul; 22(7):900-6. PubMed ID: 15975106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin.
    Cameron C; Coyle D; Ur E; Klarenbach S
    CMAJ; 2010 Jan; 182(1):28-34. PubMed ID: 20026626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.